Qiagen N.V. QGEN
50.41 USD +0.06 (+0.12%)
Nov 3, 2026, 3:25 PM EST
50.24 Day range 50.42
32.63 52-week range 55.66
- YTD
- +12.09%
- 1 year
- +10.35%
Analyst view
Consensus: hold
Hold
Price target (mean) 49.02 -2.8% downside
Now 50.41
- Target (low)
- 40.00
- Target (mean)
- 49.02
- Target (high)
- 53.00
Ratings (0m) 12 1 buy · 11 hold · 0 sell
- Strong buy1
- Buy0
- Hold11
- Sell0
- Strong sell0
Recommendation trend
- This month 12
- 1 month ago 16
- 2 months ago 15
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.62725 | 0.61 – 0.65 | 0.64211 | -2.3% | 538.14M | +1.0% | 9 |
| Next quarter | 0.65413 | 0.64 – 0.67 | 0.62 | +5.5% | 573.08M | +6.0% | 9 |
| Current year | 2.44 | 2.42 – 2.47 | 2.38 | +2.4% | 2.14B | +2.2% | 12 |
| Next year | 2.61 | 2.57 – 2.71 | 2.44 | +7.3% | 2.24B | +5.0% | 12 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 28, 2026 | Barclays | Downgrade | Overweight | Equal-Weight |
| Oct 26, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Oct 22, 2026 | JP Morgan | Downgrade | Overweight | Neutral |
| Oct 22, 2026 | Baird | Maintained | Outperform | Outperform |
| Oct 14, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 6, 2026 | Barclays | Upgrade | Equal-Weight | Overweight |
| Sep 9, 2026 | UBS | Maintained | Neutral | Neutral |
| Aug 10, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Aug 7, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Aug 7, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jun 23, 2026 | Morgan Stanley | Upgrade | Equal-Weight | Overweight |
| May 18, 2026 | Stifel | Maintained | Hold | Hold |
| May 7, 2026 | TD Cowen | Maintained | Hold | Hold |
| Apr 29, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Apr 29, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Apr 29, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Apr 29, 2026 | Baird | Upgrade | Neutral | Outperform |
| Apr 14, 2026 | Barclays | Downgrade | Overweight | Equal-Weight |
| Mar 13, 2026 | Deutsche Bank | Upgrade | Hold | Buy |
| Feb 6, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Feb 6, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Feb 6, 2026 | Stifel | Maintained | Hold | Hold |
| Jan 22, 2026 | Deutsche Bank | Downgrade | Buy | Hold |
| Dec 15, 2025 | Barclays | Maintained | Overweight | Overweight |
| Dec 11, 2025 | Citigroup | Downgrade | Buy | Neutral |
| Oct 2, 2025 | Barclays | Maintained | Overweight | Overweight |
| Aug 7, 2025 | UBS | Maintained | Neutral | Neutral |
| Jun 26, 2025 | B of A Securities | Maintained | Buy | Buy |
| Jun 24, 2025 | Barclays | Initiated | — | Overweight |
| Apr 21, 2025 | Baird | Maintained | Neutral | Neutral |
